Clinical Trial Update: DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial update on direct-acting antivirals (DAAs) for patients with chronic hepatitis C infection and HBV coinfection; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hbv Coinfection
• Hepatitis B
• Hepatitis C

Snippet

Sponsor: Humanity and Health Research Centre | Conditions: Chronic Hepatitis C Infection, HBV Coinfection | Phase 2, Phase 3 | Status: COMPLETED